Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Animal models of mucositis: critical tools for advancing pathobiological understanding and identifying therapeutic targets
Author: Wardill, H.
Tissing, W.
Kissow, H.
Stringer, A.
Citation: Current Opinion in Supportive and Palliative Care, 2019; 13(2):119-133
Publisher: Lippincott, Williams & Wilkins
Issue Date: 2019
ISSN: 1751-4258
Statement of
Hannah R. Wardill, Wim J.E. Tissing, Hannelouise Kissow and Andrea M. Stringer
Abstract: PURPOSE OF REVIEW:Mucositis remains a prevalent, yet poorly managed side effect of anticancer therapies. Mucositis affecting both the oral cavity and gastrointestinal tract predispose to infection and require extensive supportive management, contributing to the growing economic burden associated with cancer care. Animal models remain a critical aspect of mucositis research, providing novel insights into its pathogenesis and revealing therapeutic targets. The current review aims to provide a comprehensive overview of the current animal models used in mucositis research. RECENT FINDINGS:A wide variety of animal models of mucositis exist highlighting the highly heterogenous landscape of supportive oncology and the unique cytotoxic mechanisms of different anticancer agents. Golden Syrian hamsters remain the gold-standard species for investigation of oral mucositis induced by single dose and fractionated radiation as well as chemoradiation. There is no universally accepted gold-standard model for the study of gastrointestinal mucositis, with rats, mice, pigs and dogs all offering unique perspectives on its pathobiology. SUMMARY:Animal models are a critical aspect of mucositis research, providing unprecedent insight into the pathobiology of mucositis. Introduction of tumour-bearing models, cyclic dosing scheduled, concomitant agents and genetically modified animals have been integral in refining our understanding of mucositis.
Keywords: Animal models, mucositis; pathobiology; preclinical
Rights: © 2019 Wolters Kluwer Health, Inc. All rights reserved.
RMID: 0030117209
DOI: 10.1097/SPC.0000000000000421
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_119869.pdfAccepted version523.21 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.